DNLI vs GE · $2.11B cap vs P/E 44, rev $45.85B
Denali Therapeutics Inc (DNLI) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
DNLI currently screens at market cap $2.11B. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the DNLI and GE stock pages for the full models.
Not investment advice.